Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Erik Ostrowski | M | 51 | 5 years | |
| Philip Donenberg | M | 63 | 6 years | |
| Ian Clark | M | 62 | 6 years | |
| Philip Vickers | M | 64 | 5 years | |
| Annalisa Jenkins | M | 58 | 6 years | |
| Steven Avruch | M | 63 | 5 years | |
| Ruben Jose King-Shaw | M | 63 |
University of Massachusetts
| 19 years |
| Fergus M. Clydesdale | M | 87 |
University of Massachusetts
| 20 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Harald F. Stock | M | 56 |
OvaScience, Inc.
 OvaScience, Inc. Pharmaceuticals: MajorHealth Technology OvaScience, Inc. engages in the research and development of female infertility treatments. Its portfolio includes AUGMENT, OvaPrime, OvaTure, and OvaXon which intends to improve the female's egg health and reserve. The company was founded by Rich H. Aldrich, Michelle Dipp, Jonathan L. Tilly, and Christoph H. Westphal on April 5, 2011 and is headquartered in Waltham, MA. | 3 years |
| Chris Kroeger | M | - |
OvaScience, Inc.
OvaScience, Inc. Pharmaceuticals: MajorHealth Technology OvaScience, Inc. engages in the research and development of female infertility treatments. Its portfolio includes AUGMENT, OvaPrime, OvaTure, and OvaXon which intends to improve the female's egg health and reserve. The company was founded by Rich H. Aldrich, Michelle Dipp, Jonathan L. Tilly, and Christoph H. Westphal on April 5, 2011 and is headquartered in Waltham, MA. | 1 years |
| David Rothstein | M | - |
Brooklyn College
| 8 years |
| Joshua Resnick | M | 49 | 2 years | |
| Matthew Brown | M | 42 |
University of Massachusetts
| 4 years |
| Katina Dorton | F | 66 | 1 years | |
| Thomas Malley | M | 55 |
OvaScience, Inc.
OvaScience, Inc. Pharmaceuticals: MajorHealth Technology OvaScience, Inc. engages in the research and development of female infertility treatments. Its portfolio includes AUGMENT, OvaPrime, OvaTure, and OvaXon which intends to improve the female's egg health and reserve. The company was founded by Rich H. Aldrich, Michelle Dipp, Jonathan L. Tilly, and Christoph H. Westphal on April 5, 2011 and is headquartered in Waltham, MA. | 5 years |
| Arthur Tzianabos | M | 60 |
OvaScience, Inc.
OvaScience, Inc. Pharmaceuticals: MajorHealth Technology OvaScience, Inc. engages in the research and development of female infertility treatments. Its portfolio includes AUGMENT, OvaPrime, OvaTure, and OvaXon which intends to improve the female's egg health and reserve. The company was founded by Rich H. Aldrich, Michelle Dipp, Jonathan L. Tilly, and Christoph H. Westphal on April 5, 2011 and is headquartered in Waltham, MA. | 3 years |
| Evan Campbell | M | - |
University of Massachusetts
| 8 years |
| Theresa McNeely | F | 60 |
OvaScience, Inc.
OvaScience, Inc. Pharmaceuticals: MajorHealth Technology OvaScience, Inc. engages in the research and development of female infertility treatments. Its portfolio includes AUGMENT, OvaPrime, OvaTure, and OvaXon which intends to improve the female's egg health and reserve. The company was founded by Rich H. Aldrich, Michelle Dipp, Jonathan L. Tilly, and Christoph H. Westphal on April 5, 2011 and is headquartered in Waltham, MA. | 3 years |
| Kenneth Barry Rodwogin | M | - |
Brooklyn College
| 8 years |
| David Sinclair | M | - |
OvaScience, Inc.
OvaScience, Inc. Pharmaceuticals: MajorHealth Technology OvaScience, Inc. engages in the research and development of female infertility treatments. Its portfolio includes AUGMENT, OvaPrime, OvaTure, and OvaXon which intends to improve the female's egg health and reserve. The company was founded by Rich H. Aldrich, Michelle Dipp, Jonathan L. Tilly, and Christoph H. Westphal on April 5, 2011 and is headquartered in Waltham, MA. | 6 years |
| Scott Requadt | M | 56 | 2 years | |
| John P. Howe | M | 81 |
OvaScience, Inc.
OvaScience, Inc. Pharmaceuticals: MajorHealth Technology OvaScience, Inc. engages in the research and development of female infertility treatments. Its portfolio includes AUGMENT, OvaPrime, OvaTure, and OvaXon which intends to improve the female's egg health and reserve. The company was founded by Rich H. Aldrich, Michelle Dipp, Jonathan L. Tilly, and Christoph H. Westphal on April 5, 2011 and is headquartered in Waltham, MA. | 3 years |
| Murray Stahl | M | 70 |
Brooklyn College
| 6 years |
| William Everett Dodge | M | - |
University of Massachusetts
| 34 years |
| Myles Allen Grenier | M | - |
University of Massachusetts
| 3 years |
| Robert Doane | M | - |
University of Massachusetts
| 4 years |
| Juan E. Avendano | M | - |
University of Massachusetts
| 4 years |
| Victor G. Siu | M | - |
University of Massachusetts
| 4 years |
| Travis James Gross | M | - |
University of Massachusetts
| 5 years |
| Michelle Torchia | F | - |
University of Massachusetts
| 2 years |
| Brian Hueter | M | - |
University of Massachusetts
| 4 years |
| Jeffrey A. Mehlman | M | - |
University of Massachusetts
| 2 years |
| Nerissa Kreher | M | 51 | 2 years | |
| Melissa A. Lockett | F | - |
University of Massachusetts
| 4 years |
| Candice Kakar | F | - |
University of Massachusetts
| 4 years |
| Amy Ko | F | - |
University of Massachusetts
| 5 years |
| Brett C. Watson | M | - |
University of Massachusetts
| 4 years |
| Laura McDonough | F | - |
University of Massachusetts
| 4 years |
| Jennifer Andersen | F | 37 |
University of Massachusetts
| 4 years |
| Jo Ann M. Gora | M | 78 |
University of Massachusetts
| 3 years |
| Tim Reardon | M | - |
University of Massachusetts
| 4 years |
| Michael LaCorte | M | - |
University of Massachusetts
| 4 years |
| Fran Peters | M | - |
University of Massachusetts
| - |
| Jeremy Holtz | M | - |
University of Massachusetts
| 4 years |
| Matan Amir | M | 46 |
University of Massachusetts
| 4 years |
| Derek Khanna | M | - |
University of Massachusetts
| 3 years |
| Jessica Botelho | F | - |
University of Massachusetts
| 4 years |
| Yi Zhong | M | 51 |
University of Massachusetts
| 2 years |
| Larry Rubin | M | - |
Brooklyn College
| 4 years |
| Sun Altbach | F | - |
OvaScience, Inc.
OvaScience, Inc. Pharmaceuticals: MajorHealth Technology OvaScience, Inc. engages in the research and development of female infertility treatments. Its portfolio includes AUGMENT, OvaPrime, OvaTure, and OvaXon which intends to improve the female's egg health and reserve. The company was founded by Rich H. Aldrich, Michelle Dipp, Jonathan L. Tilly, and Christoph H. Westphal on April 5, 2011 and is headquartered in Waltham, MA. | 2 years |
| Brennan Michael Jones | M | - |
University of Massachusetts
| 4 years |
| Dan Conklin | M | - |
University of Massachusetts
| 4 years |
| Jacob Gordon | M | - |
University of Massachusetts
| 4 years |
| Georgette Verdin | F | - | - | |
| Yue Lei Shen | M | - |
University of Massachusetts
| 3 years |
| William Steinkrauss | M | 39 |
OvaScience, Inc.
OvaScience, Inc. Pharmaceuticals: MajorHealth Technology OvaScience, Inc. engages in the research and development of female infertility treatments. Its portfolio includes AUGMENT, OvaPrime, OvaTure, and OvaXon which intends to improve the female's egg health and reserve. The company was founded by Rich H. Aldrich, Michelle Dipp, Jonathan L. Tilly, and Christoph H. Westphal on April 5, 2011 and is headquartered in Waltham, MA. | 1 years |
| Yazid Tohme | M | 51 |
University of Massachusetts
| 2 years |
| Ben Myers | M | - |
University of Massachusetts
| 5 years |
| Matthew Tetreau | M | - |
University of Massachusetts
| 4 years |
| Adam Connor | M | - |
University of Massachusetts
| 4 years |
| Nathan Chesley | M | - |
University of Massachusetts
| 4 years |
| Luke Matton | M | - |
University of Massachusetts
| 4 years |
| Doug B. Lancey | M | - |
University of Massachusetts
| 4 years |
| Can Wu Hu | M | 48 |
University of Massachusetts
| 3 years |
| Ben Stein | M | - |
University of Massachusetts
| 4 years |
| Carole A. Billington | F | - |
University of Massachusetts
| 4 years |
| John McCabe | M | 55 |
University of Massachusetts
| 4 years |
| Thomas Patrick Craven | M | - |
University of Massachusetts
| 3 years |
| Lindsay Chisholm | F | 43 |
University of Massachusetts
| 3 years |
| Thomas Weisman | M | - |
University of Massachusetts
| 2 years |
| Meagan Swanson | F | - |
University of Massachusetts
| 4 years |
| Andrew Lester | M | 69 |
Brooklyn College
| 4 years |
| Peter Trovato | M | - |
University of Massachusetts
| 4 years |
| Matt Penney | M | - |
University of Massachusetts
| 4 years |
| Matthew Daniels | M | - |
University of Massachusetts
| 1 years |
| Christian Walker | M | - |
University of Massachusetts
| 2 years |
| Jennifer Leonard | F | - |
University of Massachusetts
| 4 years |
| Dave Melevsky | M | - |
University of Massachusetts
| 2 years |
| Neil Steven Crespi | M | - |
Brooklyn College
| 4 years |
| Robert Conley | M | - |
University of Massachusetts
| 4 years |
| Alex Forse | M | 40 |
University of Massachusetts
| 1 years |
| Anjaneya K. Singh | M | - |
University of Massachusetts
| 4 years |
| Justin H. Garrison | M | - |
University of Massachusetts
| 4 years |
| Finian O'Shea | M | - |
University of Massachusetts
| 4 years |
| Birgitte Volck | M | 61 | 2 years | |
| Joseph Tepfer | M | - |
Brooklyn College
| 4 years |
| Eric Wisman | M | - |
University of Massachusetts
| 3 years |
| David Gudek | M | - |
University of Massachusetts
| 4 years |
| Megan Alice McGregor | F | - |
University of Massachusetts
| 4 years |
| John D. Eisel | M | 47 |
OvaScience, Inc.
OvaScience, Inc. Pharmaceuticals: MajorHealth Technology OvaScience, Inc. engages in the research and development of female infertility treatments. Its portfolio includes AUGMENT, OvaPrime, OvaTure, and OvaXon which intends to improve the female's egg health and reserve. The company was founded by Rich H. Aldrich, Michelle Dipp, Jonathan L. Tilly, and Christoph H. Westphal on April 5, 2011 and is headquartered in Waltham, MA. | 1 years |
| Andrew Dunham | M | - |
University of Massachusetts
| 4 years |
| Lauren L. Kauders | F | - |
University of Massachusetts
| 4 years |
| Jesse Morgan | F | - |
University of Massachusetts
| 4 years |
| Josh Ginsberg | M | - |
University of Massachusetts
| 4 years |
| Ryan Durkin | M | - |
University of Massachusetts
| 4 years |
| Joe E. McGerigle | M | - |
University of Massachusetts
| 4 years |
| Anthony G. Rapsomanikis | M | - |
University of Massachusetts
| 4 years |
| Mike Nobil | M | - |
University of Massachusetts
| 4 years |
| Ricardo Signorelli | M | - |
University of Massachusetts
| 3 years |
| Christman Michael | M | - |
University of Massachusetts
| 4 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 100 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Gabriel Cohn
- Personal Network